SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, has appointed Suzette Chance, Ph.D. to serve as senior director of clinical affairs. In her role, Dr. Chance will lead clinical trial strategy and execution for Great Basin’s diagnostic products, beginning with upcoming trials for: Candida Blood Infections Panel; SA Nasal Screen Test; CT/NG Test; Stool Bacterial Pathogens Panel; and Pertussis/Parapertussis Test. All five trials are slated to begin in 2016 with expected clearance timeframes throughout 2017.
